On Jan 27, Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA) of China, met with a visiting delegation led by Mark Abdoo, associate commissioner for global regulatory operations and policy of the US Food and Drug Administration (FDA).

Both sides affirmed achievements made in China-US cooperation on drug regulation and expressed their willingness to continue practical cooperation, to jointly encourage more better products for the benefit of people in both countries.

The NMPA gave a briefing on the latest progress made in China's drug regulation and introduced the approval of the Regulations for the Implementation of the Drug Administration Law.

For their part, the US side provided updates on the FDA's key efforts made in such areas as security of drug supply chains, the establishment of a regulatory framework for digital health products, and the development of regulations for medical device quality management systems.

They also engaged in in-depth exchanges on policies related to drug imports and exports, pharmacovigilance and the application of new methodologies.

Also present at the meeting were heads of relevant departments and affiliated institutions of the NMPA, as well as representatives of the FDA's China Office and Center for Drug Evaluation and Research.